Search Results 9161-9170 of 15255 for CLL
-
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
-
The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...
-
Marla Broadfoot, Ph.D. March 26, 2026. Immunotherapy boosts chemotherapy in combating stage 3 colon cancer featured image. Cancer.
-
DEAR MAYO CLINIC: My brother has been diagnosed with depression. I want to help him, but I do not know what to do. Can you give[...].
-
Lung cancer begins as a growth of cells in the lungs. Risk factors include smoking, secondhand smoke, exposure to certain toxins and family history. Symptoms.
-
Mayo Clinic has refined a preclinical model that lays the foundation for its first-ever larynx transplant. The model assesses the unique immunosuppressive needs ...
-
This is the most common type of tumor that forms in the head and may affect the brain. Find out about symptoms, diagnosis and treatment.
-
Knowledge of DNA repair mechanisms advances with new paper from Mayo Clinic scientists featured image · Mayo Clinic launches first-in-world mate-pair sequencing ...
-
The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed acute myeloid ...
-
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...